OZY
- Product code
- OZY
- Device name
- Chlamydophila Pneumoniae Dna Assay System
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3980
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
FDA classification definition
A qualitative in vitro diagnostic assay intended to detect Chlamydophila pneumoniae DNA extracted from human respiratory specimens. Detection of Chlamydophila pneumoniae DNA aids in the diagnosis of Chlamydophila pneumoniae respiratory infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infection.
Official FDA classification page: OZY
Classification and pathway per current FDA publications. Data from openFDA (CC0).